stop_circleTerminated/Withdrawn

Bacterial Infection

Study of oral Ciprofloxacin versus Tobramycin plus Ceftazidime in the treatment of children and juveniles suffering from acute pulmonary exacerbation of cystic fibrosis

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

5 - 17 Years
  • -

  • -

Trial summary

Enrollment Goal
108
Trial Dates
February 1993 - May 1995
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Cipro (Ciprofloxacin hydrochloride, BAYO9867)
Accepts Healthy Volunteer
N/A

Trial design

Prospective, randomized, non-blind, multi-center comparative safety and efficacy study of oral Ciprofloxacin versus Tobramycin plus Ceftazidime in the treatment of children and juveniles suffering from acute pulmonary exacerbation of cystic fibrosis
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A